Prognosis marker in endometrial cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This study looks at a protein called METTL-14 in a common type of endometrial cancer (type 1). The goal is to see if the amount of this protein is linked to how the disease progresses and how long patients survive. If you have had a hysterectomy for type 1 endometrial cancer and your medical records are complete for at least three years, you might be able to participate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 1 endometrial cancer.
- You had a hysterectomy to remove your uterus.
- Your doctors have complete records of your age, symptoms, and exam findings.
- Your doctors have records of your biopsy and any imaging tests.
- Your doctors have records of your survival, whether the cancer spread or came back, and any chemotherapy you received for at least three years.
- Tissue from your cancer (a tissue block or stained slide) must still be available.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether a special kind of medicine called a PARP inhibitor can work against endometrial cancer cells grown in a lab from your tumor. The goal is to find out which patients might benefit from this treatment in the future.
This study looks at combining genetic testing with surgical exams to better understand endometrial cancer. It may help doctors see which treatments could work best for you.
This study looks for “methylated DNA markers” (special DNA patterns) to help detect endometrial, ovarian, and cervical cancers, and to support doctors around planned procedures. It may help find cancer earlier or better sort out who needs closer treatment.
This study uses two simple tests (a cell sample from the uterus and a cervical DNA test) to find endometrial cancer early and to check how well fertility-sparing treatment is working.
This study looks at how well a surgical tool is used during standard surgery for early endometrial cancer, and whether it relates to test results from fluid taken in the abdomen. It may help surgeons improve how samples are collected and interpreted during routine care.
This study looks at the specific type of endometrial cancer (endometrioid) in Mexican patients to understand how different molecular features affect prognosis. It may help doctors better tailor treatment to the individual.
Hear when a new Endometrial Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.